标准化定义预测双胎输血综合征合并选择性生长受限激光术后胎儿死亡
本研究回顾性纳入124例因双胎输血综合征行胎儿镜激光手术的单绒毛膜双羊膜囊双胎,比较三种选择性胎儿生长受限定义与术后48小时内胎儿死亡的关系。结果显示,无论采用哪种定义,选择性生长受限均与供血儿术后死亡风险升高相关,其中Delphi共识的贡献性标准(定义C)预测价值最高。
要点
- 选择性生长受限与激光术后供血儿死亡风险升高相关,三种定义均显著。
- Delphi贡献性标准(定义C)对供血儿术后死亡的预测价值最高。
- 所有供血儿死亡病例均符合定义C的选择性生长受限标准。
核心结论
- 双胎输血综合征行胎儿镜激光手术后,合并选择性生长受限者胎儿死亡率升高。
- 基于Delphi共识四项贡献性标准中至少两项的定义C对供血儿术后死亡预测价值最高。
研究设计与样本
- 回顾性队列研究,纳入2015年1月至2018年12月因双胎输血综合征行胎儿镜激光手术的单绒毛膜双羊膜囊双胎妊娠124例。
- 采用三种定义(ISUOG定义A、EFW<第3百分位定义B、Delphi贡献性标准定义C)对队列进行选择性生长受限分类。
主要发现
- 定义A识别37.1%(46/124)为选择性生长受限,定义B识别46.0%(57/124),定义C识别56.5%(70/124)。
- 三种定义下,选择性生长受限组的供血儿术后死亡率均显著高于非选择性生长受限组(定义A:28.3% vs 3.8%,P<0.01;定义B:22.8% vs 4.5%,P=0.02;定义C:22.9% vs 0%,P<0.01)。
- 三种定义下,选择性生长受限组III期双胎输血综合征比例均显著高于非选择性生长受限组(定义A:65.2% vs 35.9%,P≤0.01;定义B:59.6% vs 35.8%,P=0.04;定义C:62.9% vs 25.9%,P<0.01)。
- 所有供血儿死亡病例均符合定义C的选择性生长受限标准。
- 逻辑回归显示选择性生长受限与供血儿死亡风险升高相关(定义A:OR 4.97,95%CI 1.77-13.94,P<0.01;定义B:OR 4.39,95%CI 1.36-14.15,P=0.01),调整干预孕周和TTTS分期后结果相似(定义A:OR 6.48,95%CI 2.11-24.56,P=0.002;定义B:OR 4.16,95%CI 1.35-15.74,P=0.02)。
关键数值与推荐
- 定义A(ISUOG):一胎EFW<第10百分位且双胎EFW不一致>25%。
- 定义B(Delphi单一标准):一胎EFW<第3百分位。
- 定义C(Delphi贡献性标准):以下四项中至少两项:一胎EFW<第10百分位、一胎腹围<第10百分位、双胎EFW不一致≥25%、较小胎脐动脉搏动指数>第95百分位。
临床怎么用
- 对双胎输血综合征行胎儿镜激光手术前,应标准化评估选择性生长受限以改善咨询。
- 采用Delphi贡献性标准(定义C)可能提高对供血儿术后死亡的预测。
- 选择性生长受限合并TTTS者术后需加强供血儿监测。
局限性
- 回顾性队列研究设计。
- 样本量124例,来自单中心。
- 仅评估术后48小时内胎儿死亡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Selective fetal growth restriction (sFGR) complicating twin-twin transfusion syndrome (TTTS) is associated with a 3-6-fold increased risk of fetal demise after fetoscopic laser surgery (FLS). Identifying these patients is challenging due to varying definitions of sFGR used in the literature. The objective of this study was to determine the association of three currently used definitions for sFGR with demise of the smaller twin, typically the donor, following FLS for TTTS. METHODS: This was a retrospective cohort study of monochorionic diamniotic twin pregnancies undergoing FLS for TTTS between January 2015 and December 2018. Classification of the cohort as sFGR or non-sFGR was performed using three different definitions: (1) estimated fetal weight (EFW) of one twin < 10th centile and intertwin EFW discordance > 25%, according to the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) (Definition A); (2) EFW of one twin < 3rd centile, according to the solitary criterion for sFGR reported in a Delphi consensus (Definition B); and (3) presence of at least two of four of the following criteria: EFW of one twin < 10th centile, abdominal circumference of one twin < 10th centile, intertwin EFW discordance of ≥ 25% and umbilical artery pulsatility index of the smaller twin > 95th centile, according to the contributory criteria for sFGR in monochorionic diamniotic twin pregnancies reported in the Delphi consensus (Definition C). Pearson's χ2 and univariate and multivariate logistic regression analyses were performed to assess the association of classification as sFGR according to the different definitions with fetal demise within 48 h after FLS. RESULTS: A total of 124 pregnancies underwent FLS for TTTS during the study period. Of these, 46/124 (37.1%) were identified as having sFGR according to the ISUOG criteria (Definition A), 57/124 (46.0%) based on EFW < 3rd centile (Definition B) and 70/124 (56.5%) according to the Delphi contributory criteria (Definition C). There were no differences in maternal body mass index, recipient twin amniotic fluid volume, gestational age (GA) at intervention or GA at delivery between sFGR and non-sFGR cases for any of the three definitions. There were also no differences in the rates of postprocedure recipient demise or Doppler abnormalities in the recipient. Regardless of the definition used, sFGR cases showed a significantly higher rate of postprocedure donor twin demise compared with that in non-sFGR cases (Definition A: 28.3% vs 3.8%, P < 0.01; Definition B: 22.8% vs 4.5%, P = 0.02; Definition C: 22.9% vs 0%, P < 0.01). For all of the sFGR definitions, the rate of Stage-III TTTS was increased in sFGR compared to non-sFGR cases (Definition A: 65.2% vs 35.9%, P ≤ 0.01; Definition B: 59.6% vs 35.8%, P = 0.04; Definition C: 62.9% vs 25.9%, P < 0.01). All cases of donor demise met the criteria for sFGR according to Definition C. Classification as sFGR according to Definition C was associated with a significantly higher rate of post-FLS donor demise compared to Definitions A and B (χ2 , 15.32; P < 0.01). Logistic regression analysis demonstrated that sFGR cases had an increased risk of donor demise (Definition A: odds ratio (OR), 4.97 (95% CI, 1.77-13.94), P < 0.01; Definition B: OR, 4.39 (95% CI, 1.36-14.15), P = 0.01) and that staging of TTTS was also predictive of demise (OR, 2.26 (95% CI, 1.14-4.47), P = 0.02). After adjusting for GA at intervention and stage of TTTS, the results were similar (Definition A: OR, 6.48 (95% CI, 2.11-24.56), P = 0.002; Definition B: OR, 4.16 (95% CI, 1.35-15.74), P = 0.02). CONCLUSIONS: The rate of fetal demise following FLS for TTTS is increased in the presence of sFGR. Improving diagnosis of sFGR should improve counseling and may affect management. The Delphi method of defining sFGR based on the presence of at least two of four contributory criteria had the highest predictive value for donor demise following FLS for TTTS. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Donepudi R, Espinoza J, Nassr AA, et al. Prediction of post-laser fetal death in selective growth restriction complicating twin-twin transfusion syndrome using standardized definitions. Ultrasound Obstet Gynecol. 2021. PMID: 33073885. doi:10.1002/uog.23519
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。